Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
novel transcript, antisense to SHD and CCDC94 (ENSG00000303295)
- Target
- ENSG00000303295
- Molecular classification
- Other (likely long non-coding RNA, non-coding RNA)
01
Overview
This gene, "novel transcript, antisense to SHD and CCDC94" (ENSG00000303295), refers to a non-coding RNA transcript located antisense to both SHD (Src homology 2 domain containing transforming protein D) and CCDC94 (coiled-coil domain containing 94) genes. It is annotated as a transcript locus in genomic variant databases but is not characterized functionally or as a therapeutic target. There is no established evidence for biological function, disease association, molecular pathway, biomarker role, or druggability. The lack of literature, characterized protein product, and target validation strongly indicate this is not a bona fide therapeutic target and should be considered an uncharacterized or ambiguous non-coding genomic region.
- Other names
- novel transcript, antisense to SHD and CCDC94
02
Mechanism of action
null
Beyond the preview
Go deeper on novel transcript, antisense to SHD and CCDC94 (ENSG00000303295).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on novel transcript, antisense to SHD and CCDC94 (ENSG00000303295).